skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: This company seems to have reasonable ROE (just under 20) and good growth but has sold off with several large blocks transacting recently despite positive analyst coverage. It reports this week so I don't plan to jump into a position but I wanted 5i's opinion on whether mid $30's represents an attractive entry point for a company that has exposure to a variety of Pharma companies? Would it be a buy, sell or hold for you and what would it take in terms of a news event or drop in price to make it a buy? What do you like and/or dislike about the company?
Thanks!
Read Answer Asked by Tim on August 11, 2021
Q: Hi group I am light on Health care + Manufacturing stocks what are your top 3 recommendations in both stocks / ETFs and why Thanks for your guidance
Read Answer Asked by Terence on August 11, 2021
Q: Hello 5i
Could you please give me your opinion on Vaxart. Thank you, Bill
Read Answer Asked by William on August 11, 2021
Q: With the senior demographic gaining in numbers what is your feeling about ADUS as an outpatient and home healthcare company.

Could you please list your top 3 recommendations, in both US and Canada, for this Healthcare industry.
Read Answer Asked by micheal on August 10, 2021
Q: Hello Peter, Ryan and your amazing team!

Wondering if you could please give me your current take on Guardant Health considering their recent earnings and news about Covid testing. Are you still a strong advocate of holding this stock patiently, with the hope that a significant advancement will eventually propel the SP? Thank you.
Read Answer Asked by Bradley on August 10, 2021
Q: I bought GUD as a long term investment. It worries me when you say you are losing patience with it and I suspect you will take it out of the portfolio if you find a very compelling replacement for that sector. But has anything fundamentally changed from when you included it in the portfiloio besides the time it is taking to spend the horde of cash?
Read Answer Asked by Don on August 06, 2021
Q: I am having difficulty making sense of the recent loss for this company. The results appear to be penalized by losses applying to a change in the fair value of debentures as well as derivatives which together are greater than the EBITDA earnings. I was wondering how relevant these are to the company's prospects and whether the resulting valuation justified the fall in the share price. Thank you for your response.
Read Answer Asked by Mike on August 06, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!